Molecular analysis of minimal residual disease in adult acute lymphoblastic leukaemia

Best Practice and Research: Clinical Haematology

Volumn 15, Issue 1, 2002, Pages 71-90

  Foroni, Letizia ^a   Hoffbrand, A Victor ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Adult ALL; B lineage ALL; Minimal residual disease

Indexed keywords

ANTINEOPLASTIC AGENT; T LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; MOLECULAR MARKER; TUMOR MARKER;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOTRANSPLANTATION; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW BIOPSY; CANCER RECURRENCE; CANCER SURVIVAL; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN GENE; LEUKEMIA REMISSION; MALE; MINIMAL RESIDUAL DISEASE; MOLECULAR CLONING; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; TREATMENT OUTCOME; TREATMENT PLANNING; AGE; ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; B LYMPHOCYTE; CELL LINEAGE; CLONAL VARIATION; COMPARATIVE STUDY; GENE; HIGH RISK POPULATION; LEUKEMIA RELAPSE; MONITORING; REVIEW; STEM CELL TRANSPLANTATION; VH GENE; ACUTE LYMPHOCYTIC LEUKEMIA; B CELL LEUKEMIA; CELL CLONE; CHEMISTRY; METABOLISM; MORTALITY; PATHOLOGY;

ADULT; CLONE CELLS; HUMANS; LEUKEMIA, B-CELL, ACUTE; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; NEOPLASM, RESIDUAL; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036009607     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1053/beha.2002.0186     Document Type: Article

References (62)

1. Recent approaches in acute lymphoblastic leukemia in adults
2. The Medical Research Council trials in adult acute lymphocytic leukemia
3. Immunophenotyping of leukemia
4. The management of patients with leukaemia: The role of cytogenetics in this molecular era
5. Spectral karyotyping and multicolor fluorescence in situ hybridisation reveal new tumour-specific chromosomal aberrations
6. Expression of Wilms tumor gene (WTI) in children with acute leukemia
7. Low incidence of TALI gene rearrangements in adult acute lymphoblastic leukemia: A cancer and leukemia group B study (8762)
8. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults
9. ATM gene deletion in patients with adult acute lymphoblastic leukemia
10. Deletions in the 13q14 locus in adult lymphoblastic leukemia: Rate of incidence and relevance
11. Cell cycle regulatory gene abnormalities are important determinants of leukemogenesis and disease biology in adult acute lymphoblastic leukemia
12. Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia
13. Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia
14. Adult Leukaemia Working Party. TEL-AML1 fusion in acute lymphoblastic leukaemia of adults
15. Somatic generation of antibody diversity
16. Development of the primary antibody repertoire
17. Analysis of T immunoglobulin and T cell receptor genes. Part I, basic and technical aspects
18. Analysis of immunoglobulin and T cell receptor genes. Part II, possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders
19. Quantitation of targets for PCR by use of limiting dilution
20. The use of monoclonal gene rearrangement for detection of minimal residual disease in acute lymphoblastic leukemia of childhood
21. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia
22. Prognostic value of minimal residual disease in acute lymphoblastic leukemia in children
23. Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations
24. The use of IgH fingerprinting and ASO-dependent PCR for the investigation of residual disease (MRD) in ALL
25. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia
26. Investigation of minimal residual disease in childhood and adult lymphoblastic leukemia by molecular analysis
27. Real time quantitative PCR
28. Application of germiline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia
29. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes
30. Precursor-B-All with DH-JH gene rearrangements have an immature immunophenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14
31. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: Implication for the selection of PCR targets for detection of minimal residual disease
32. Immunoglobulin heavy chain gene fingerprinting reveals widespread oligoclonality in B-lineage acute lymphoblastic leukemia
33. Biologic and prognostic significance of the presence of more than two mu heavy-chain genes in childhood acute lymphoblastic leukemia of B precursor cell origin
34. Distinct ongoing lg heavy chain rearrangement processes in childhood B-precursor acute lymphoblastic leukemia
35. Molecular analysis of rearranged VH genes during B cell chronic lymkphocytic leukemia: Intraclonal stability is frequent but not constant
36. Immunoglobulin heavy chain gene rearrangement in adult acute lymphoblastic leukemia reveals preference of JH-proximal variable gene segments
37. VH to VHDNJH rearrangement is mediated by the internal VH heptamer
38. Immunoglobulin V gene replacement is caused by the intramolecular DNA deletion mechanism
39. The DNJH complex remains active in recombination to VH segments after the loss of mu-chain expression in mu-positive pre-B cells
40. A novel VH to VHDNJH joining mechanism in heavy-chain-negative (null) pre B cells results in heavy-chain production
41. Clonal evolution in B-lineage acute lymphoblastic leukemia by contemporaneous VH-VH gene replacements and VH-DNJH gene rearrangements
42. Oligoclonality: An insight into the biology of acute lymphoblastic leukaemia
43. Mechanisms of relapse in acute lymphoblastic leukemia: Involvement of p53 mutated subclones in disease progression
44. Clonal diversity of lg and T-cell-receptor gene rearrangements identifies a subset of childhood B-precursor acute lymphoblastic leukemia with increased risk of relapse
45. Molecular analysis of the leukaemic B cell in adult and childhood acute lymphoblastic leukaemia
46. Detection and quantification of neoplastic cells in acute lymphoblastic leukaemia, by use of the polymerase chain reaction
47. Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia
48. Minimal residual disease (MRD) tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia
49. High BCR-ABL transcript levels precede haematological relapse in Philadelphia positive acute leukemia
50. Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia
51. Rapid, multifluorescent TCRG Vgamma and Jgamma typing: Application to T cell acute lymphoblastic leukemia and to the detection of minor clonal populations
52. Comparison of different polymerase chain reaction-based approaches for clonality assessment of immunoglobulin heavy-chain gene rearrangements in B-cell neoplasia
53. Monitoring minimal residual disease in peripheral blood in B-lineage acute lymphoblastic leukaemia
54. Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow
55. Prospective monitoring and quantification of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of the δ and γ T-cell receptor genes
56. Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumour cells in peripheral blood stem cells for autotransplantation
57. PCR assessment of bone marrow status in 'isolated' extramedullary relapse of childhood B-precursor acute lymphoblastic leukaemia
58. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma
59. Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplantation
60. Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation
61. Residual leukemia and immunomagnetic bead purging in patients with BCR-ABL-positive acute lymphoblastic leukemia
62. Gene-marking to trace origin of relapse after autologous bone marrow transplantation